ClinicalTrials.gg
CompletedNCT03340857Updated Feb 5, 2020

Intelligent Electric Bicycle for Health (VELIS) to Optimize the Return to Physical Activity for Oncology Patients

An interventional study of Intelligent electric bicycle (VELIS) sessions in Cancer and Oncology, sponsored by Fondation Audavie. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-05.

Sponsored by Fondation Audavie · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this pilot study is to encourage oncology patients to continue effort retraining after their release from rehabilitation and recuperative care facilities with physical activity sessions and therapeutic education using an intelligent electric bicycle (VELIS)

Read the detailed description

The benefit of physical activity in oncology is now clearly established. Physical activity has its place at all stages of the fight against cancer in primary, secondary and tertiary prevention.

Rehabilitation and recuperative care facilities may be a first step for patients with significant deconditioning, but long-term benefits are essential.

Nevertheless, the post rehabilitation and recuperative care facilities transition period is for these patients a temporary period during which they may loose part of the benefit of effort retraining and physical reconditioning.

The investigators believe that it is necessary to go beyond the "physiological" efficiency to identify and overcome the patient's stereotypes regarding physical activity, to customize and adapt the programs to each patient, and to bring quickly the notion of pleasure and success in the practice of physical activity. Electrically assisted bicycles can reach most of these goals provided that they are adapted.

The objective of this project is to set up and evaluate, thanks to a monocentric pilot study, a process of continuation of exercise retraining through physical activity and therapeutic education sessions for the promotion of physical activity, focusing on the use of electrically assisted bicycles, in continuation of an exercise retraining in rehabilitation and recuperative care facilities.

02

Conditions studied

  • Cancer
  • Oncology

Keywords

  • Post-cancer retraining
  • Physical activity
  • Intelligent electric bicycle
03

In context

Neoplasms

10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's enrollment of 14 is below the median of 60 across 7,703 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

This is the only study on the registry with Fondation Audavie as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient aged 18 and over
  • Patient who has followed a post-cancer effort retraining program in a rehabilitation facility at Rocheplane Medical Center
  • Patient with the ability to pedal on an outdoor bicycle
  • Patient with no restriction to moderate physical activity or bicycling (acute coronary disease of less than 2 years, locomotor problem of the spine or lower limbs incompatible with the practice of cycling)
  • Weight less than 125 kg (maximum load for VELIS)
  • Patient available for a 4 months follow-up

Exclusion criteria

Exclusion Criteria:

  • Patient with a restriction to the practice of moderate physical activity or bicycle (acute coronary disease of less than 2 years, locomotor problem)
  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons), pregnant, parturient, nursing mother, person deprived of liberty by judicial or administrative decision, a legal protection measure
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Intelligent electric bicycle (VELIS) sessions

    Intelligent electric bicycle (VELIS) sessions with an instructor, twice a week for 6 weeks

    Other: Intelligent electric bicycle (VELIS) sessions

Interventions

  • OtherIntelligent electric bicycle (VELIS) sessions

    Oncology patients will participate in intelligent electric bicycle (VELIS) sessions twice a week for 6 weeks after their release from a rehabilitation and recuperative care facility

06

What researchers measure

Primary outcomes

  1. Percentage of patients reaching the goal of 150 min equivalent of moderate physical activity per week (600 MET-min/week)

    Evaluated with the IPAQ questionnaire short version (International Physical Activity Questionnaire)

    Time frame: 4 Months

Secondary outcomes

  1. Quantitative analysis of kinetic physical activity evolution

    Longitudinal continue quantitative data from IPAQ score

    Time frame: Enrollment and then once a month from Month 2 to Month 4, the last week of the month, velis sessions and effort retraining excluded

  2. Evaluate the VELIS sessions feasibility n°1

    Number of cancelled sessions

    Time frame: 4 Months

  3. Evaluate the VELIS sessions feasibility n°2

    Number of incomplete sessions

    Time frame: 4 Months

  4. Evaluate the VELIS sessions feasibility n°3

    Collection of the failure reasons by the instructor

    Time frame: 4 Months

  5. Evaluate the impact on the physical capacities n°1

    Progression of the patients physical activity (clinical exam weight)

    Time frame: 4 Months

  6. Evaluate the impact on the physical capacities n°2

    Progression of the patients physical activity (heart rate)

    Time frame: 4 Months

  7. Evaluate the impact on the physical capacities n°3

    Progression of the patients physical activity (analysis of physio-cardiological criteria)

    Time frame: 4 Months

  8. Evaluate the impact on the physical capacities n°4

    Analysis of the progression during intelligent electric bicycle (VELIS) sessions with associated factors (initial gain in effort retraining)

    Time frame: 4 Months

  9. Evaluate the impact on the physical capacities n°5

    Analysis of the progression during intelligent electric bicycle (VELIS) sessions with associated factors (age)

    Time frame: 4 Months

  10. Evaluate the impact on the physical capacities n°6

    Analysis of the progression during intelligent electric bicycle (VELIS) sessions with associated factors (gender)

    Time frame: 4 Months

  11. Evaluate the impact on the physical capacities n°7

    Analysis of the progression during intelligent electric bicycle (VELIS) sessions with associated factors (pathologies)

    Time frame: 4 Months

  12. Evaluate the impact on the physical capacities n°8

    Constant-Load Exercise Test at 80% MAP (Maximum Aerobic Power) (endurance test on ergocycle)

    Time frame: 4 Months

  13. Evaluate the impact on the physical capacities n°9

    Constant-Load Exercise Test at 80% MAP (Maximum Aerobic Power) (evaluation with the quantitative Borg scale (from Pr Gunnar BORG) from 0 to 10 (the goal score is 4 to 5)).

    Time frame: 4 Months

  14. Evaluate the impact on the physical capacities n°10

    Constant-Load Exercise Test at 80% MAP (Maximum Aerobic Power) (heart rate)

    Time frame: 4 Months

  15. Evaluate the impact on the physical capacities n°11

    Constant-Load Exercise Test at 80% MAP (Maximum Aerobic Power) (visual analogical scale from 0 (no pain) to 10 (maximal pain) for the lower limbs pain. Lower value is a better outcome)

    Time frame: 4 Months

  16. Evaluate the impact on the physical capacities n°12

    Measurement of the muscular power using a handgrip (physiological parameter). Higher value is a better outcome.

    Time frame: 4 Months

  17. Improve quality of life

    Euroquol 5 dimensions scale (from 0 to 100 : higher value is a better outcome)

    Time frame: 4 Months

  18. Improve fatigue n°1

    Analogic visual scale about fatigue once a month

    Time frame: 4 Months

  19. Improve fatigue n°2

    Fatigue Piper score

    Time frame: 4 Months

  20. Improve chronic pain

    Analogic visual scale about pain once a month

    Time frame: 4 Months

  21. Improve self-esteem

    Evaluation with Rosenberg score

    Time frame: 4 Months

  22. Improve patient satisfaction

    Satisfaction survey and wish to do again intelligent electric bicycle (VELIS) sessions or to continue electric bicycle sessions

    Time frame: 4 Months

  23. Remove stereotypes that can lead to inhibition in the physical activity practice

    Evaluation of the psychological representation of physical activity using the Cancer Exercise Stereotypes Scale (CESS) questionnaire from the SENS (sport and social environment laboratory) team from Grenoble. The average value is calculated for each subscale. Adherence to positive stereotypes if value is below 4 for the following subscale : * Lack of interest in physical activity (items 1, 6, 11) * Side effects related to treatment (items 3, 8, 13, 17) * Risks related to physical activity (items 5, 10, 15) Adherence to positive stereotypes if value is greater than 4 for the subscale Benefits of physical activity (items 4, 9, 14, 18).

    Time frame: 4 Months

  24. Evolution of uses and performances during bicycle sessions at the beginning and the end of the intervention n°1

    Analysis of the parameters profiles recorded by the VELIS : heart rate monitor

    Time frame: 6 weeks

  25. Evolution of uses and performances during bicycle sessions at the beginning and the end of the intervention n°2

    Analysis of the parameters profiles recorded by the VELIS : speed

    Time frame: 6 weeks

  26. Evolution of uses and performances during bicycle sessions at the beginning and the end of the intervention n°3

    Analysis of the parameters profiles recorded by the VELIS : electric power provided by the engine

    Time frame: 6 weeks

  27. Evolution of uses and performances during bicycle sessions at the beginning and the end of the intervention n°4

    Analysis of the parameters profiles recorded by the VELIS : rate of pedaling for the reference itinerary

    Time frame: 6 weeks

07

Study locations

1 site
  • Rocheplane Medical Center
    Saint-Martin-d'Hères, Rhône-Alpes 38400, France
08

References and documents

Publications

  • Phillips SM, Alfano CM, Perna FM, Glasgow RE. Accelerating translation of physical activity and cancer survivorship research into practice: recommendations for a more integrated and collaborative approach. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):687-99. doi: 10.1158/1055-9965.EPI-13-1355. Epub 2014 Mar 5. PubMed 24599577 ↗
  • Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A; American College of Sports Medicine; American Heart Association. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007 Aug 28;116(9):1081-93. doi: 10.1161/CIRCULATIONAHA.107.185649. Epub 2007 Aug 1. PubMed 17671237 ↗
  • Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007 Aug;39(8):1435-45. doi: 10.1249/mss.0b013e3180616aa2. PubMed 17762378 ↗
  • Mielgo-Ayuso J, Aparicio-Ugarriza R, Castillo A, Ruiz E, Avila JM, Aranceta-Batrina J, Gil A, Ortega RM, Serra-Majem L, Varela-Moreiras G, Gonzalez-Gross M. Physical Activity Patterns of the Spanish Population Are Mostly Determined by Sex and Age: Findings in the ANIBES Study. PLoS One. 2016 Feb 25;11(2):e0149969. doi: 10.1371/journal.pone.0149969. eCollection 2016. PubMed 26914609 ↗
  • Pavey TG, Anokye N, Taylor AH, Trueman P, Moxham T, Fox KR, Hillsdon M, Green C, Campbell JL, Foster C, Mutrie N, Searle J, Taylor RS. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technol Assess. 2011 Dec;15(44):i-xii, 1-254. doi: 10.3310/hta15440. PubMed 22182828 ↗
  • Welker J, Cornuz J, Gojanovic B. [Electrically assisted bicycles: health enhancement or "green" gadget?]. Rev Med Suisse. 2012 Jul 25;8(349):1513-7. French. PubMed 22913003 ↗
  • Peterman JE, Morris KL, Kram R, Byrnes WC. Pedelecs as a physically active transportation mode. Eur J Appl Physiol. 2016 Aug;116(8):1565-73. doi: 10.1007/s00421-016-3408-9. Epub 2016 Jun 14. PubMed 27299435 ↗
  • Gojanovic B, Welker J, Iglesias K, Daucourt C, Gremion G. Electric bicycles as a new active transportation modality to promote health. Med Sci Sports Exerc. 2011 Nov;43(11):2204-10. doi: 10.1249/MSS.0b013e31821cbdc8. PubMed 22005715 ↗
  • Simons M, Van Es E, Hendriksen I. Electrically assisted cycling: a new mode for meeting physical activity guidelines? Med Sci Sports Exerc. 2009 Nov;41(11):2097-102. doi: 10.1249/MSS.0b013e3181a6aaa4. PubMed 19812505 ↗
  • Falzon C, Sabiston C, Bergamaschi A, Corrion K, Chalabaev A, D'Arripe-Longueville F. Development and validation of the Cancer Exercise Stereotypes Scale. J Psychosoc Oncol. 2014;32(6):708-26. doi: 10.1080/07347332.2014.955237. PubMed 25174265 ↗
  • Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998 May;25(4):677-84. PubMed 9599351 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2017 to primary completion in Oct 2018, 12 months.

Of 1,981 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's 12 months is below that.

Counting every sponsor, half of 2,056 studies reached it within 29 months; a quarter within 13 and three quarters within 52.

Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2017
First posted
Nov 14, 2017
StartActual
Oct 9, 2017
Primary completionActual
Oct 30, 2018
CompletionActual
Dec 30, 2018
Last update
Feb 5, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 5, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03340857
Lead sponsor
Fondation Audavie
Collaborators
Floralis, eBikeLabs, Rocheplane Medical Center
Responsible party
Sponsor
First posted
Nov 14, 2017
Start date
Oct 9, 2017
Primary completion
Oct 30, 2018
Completion
Dec 30, 2018
Last update
Feb 5, 2020

Study contacts

Jean-Luc Bosson, MD
principal investigator · Laboratoire TIMC - Themas

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion